Highlights
A collection of news and information related to Roche Holding AG published by this site and its partners.
Displaying items 1-12 of 33
» View courant.com items only
1
2
3
•
Next >
-
New help for basal cell skin cancer patients
HealthOn Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell... -
Roche, Sigma teamed up for failed Life Technologies bid -sources
ReutersBy Soyoung Kim and Greg Roumeliotis NEW YORK, May 21 (Reuters) - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said. Life Tech, the genetic...Tags: Medical Research, Sigma-Aldrich Corporation, Illumina, Inc.
-
Pfizer halts study of lymphoma drug unlikely to help survival
Reuters(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not...Tags: Biotechnology, Science and Technology, Hodgkin's Lymphoma, Leukemia, Chemotherapy
-
New cancer tools allow patients to reconsider chemo
ReutersLOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...Tags: Biotechnology, Heart Problems, Medical Specialization, Mastectomy, Genomic Health Incorporated
-
CORRECTED-Data show new Roche leukemia drug may improve on Rituxan
Reuters(Corrects paragraph 12 to show Biogen has stake in new drug) By Bill Berkrot May 15 (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as...Tags: Biotechnology, Medical Research, Leukemia, Science and Technology, Heart Disease
-
Market Chatter-Corporate finance press digest
ReutersMay 16 (Reuters) - The following corporate finance-related stories were reported by media on Thursday: * Dish Network Corp has lined up four banks to finance its $25.5 billion bid for Sprint Nextel Corp, escalating the bidding war against Japanese...Tags: Drugs and Medicines, Banking, Economy, Business and Finance, Bain Capital, LLC, Personal Service
-
EXCLUSIVE-Roche exploring sale of diabetes device unit
ReutersBy Jessica Toonkel NEW YORK, May 15 (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased...Tags: Bayer AG, Government Health Care, Medtronic Incorporated, Diabetes, Germany
-
Exclusive: Roche exploring sale of diabetes device unit
ReutersNEW YORK (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased competition and reimbursement...Tags: Bayer AG, Johnson & Johnson Inc., Government Health Care, Medtronic Incorporated, Diabetes
-
Roche immunotherapy shows response over range of cancers
ReutersBy Bill Berkrot May 15 (Reuters) - An experimental Roche Holding AG drug that helps the immune system attack tumors was well tolerated and demonstrated an impressive effect against a variety of cancers, according to preliminary trial results released on...Tags: Renal cell carcinoma, Medical Research, Bristol Myers Squibb Company, Litigation, Inflammation
-
FDA approves Roche diagnostic for gene mutation in lung cancer
ReutersMay 14 (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in...Tags: Genentech Inc., Chemotherapy, Food and Drug Administration, Medical Procedures and Tests, Lung Cancer
-
Bill would regulate 'biosimilar' drugs
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
Tags: Genentech Inc., Food and Drug Administration, U.S. Senate Committee on Appropriations, Pharmaceuticals, Exports
-
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Moody's Corporation, Medical Research, Bristol Myers Squibb Company, Novartis AG, AstraZeneca Plc
Feb 1, 2012
| Allentown Morning Call
May 21, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Reuters
May 12, 2013
|Story| Los Angeles Times
May 8, 2013
|Story| Reuters
Original site for Roche Holding AG topic gallery.
